{"nct_id":"NCT04928846","title":"A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-03-25","start_date_type":"ACTUAL","primary_completion_date":"2028-03","primary_completion_date_type":"ESTIMATED","completion_date":"2028-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}